Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Novel drug targets and potential combinations in childhood brain tumours

Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany
Novel drug targets and potential combinations in childhood brain tumours ( Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany )
26 Jun 2014

Philadelphia chromosome and the role it plays in chronic myeloid leukaemia

Prof Christine Harrison - Newcastle University, Newcastle, UK
Philadelphia chromosome and the role it plays in chronic myeloid leukaemia ( Prof Christine Harrison - Newcastle University, Newcastle, UK )
20 Jun 2014

Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody

Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany
Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody ( Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany )
20 Jun 2014

Novel targeting in acute myeloid leukaemia

Prof Giovanni Martinelli - University of Bologna, Bologna, Italy
Novel targeting in acute myeloid leukaemia ( Prof Giovanni Martinelli - University of Bologna, Bologna, Italy )
20 Jun 2014

Better understandings of gene mutations aid diagnostic tools in CLL

Dr Elías Campo - University of Barcelona, Barcelona, Spain
Better understandings of gene mutations aid diagnostic tools in CLL ( Dr Elías Campo - University of Barcelona, Barcelona, Spain )
19 Jun 2014

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy
Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )
6 Jun 2014

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma

Prof Mario Sznol - Yale Cancer Center, New Haven, USA
Ipilimumab and nivolumab achieves long-term survival in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )
2 Jun 2014

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US
HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer ( Dr Christian S. Hinrichs - Center for Cancer Research, Bethesda, US )
2 Jun 2014

ASCO 2014 roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Jun 2014

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer

Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France
Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )
2 Jun 2014

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early-stage HER2-positive breast cancer

Dr Edith Perez - Mayo Clinic, Rochester, USA
Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early-stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
1 Jun 2014

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer

Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer ( Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )
1 Jun 2014